Jupiter Neurosciences, Inc. JUNS
2.43 USD +0.12 (+5.19%)
At closeNov 3, 2026, 4:02 PM EST
2.43 0.00 0.00%
After hours · Nov 3, 4:02 PM ET
2.27 Day range 2.47
2.05 52-week range 103.50
- YTD
- -96.82%
- 1 year
- -97.55%
Financial health
Altman Z-Score
-23.06 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -4.1×
FY 2019 5y median -36.6× FY 2025
P/S 1621×
FY 2019 5y median 81.6× FY 2025
P/B -19.3×
FY 2019 5y median -19.3× FY 2025
P/FCF -6.5×
FY 2019 5y median -78.7× FY 2025
EV/EBITDA -4.3×
FY 2019 5y median -40.0× FY 2025
EV/Sales 1691×
FY 2019 5y median 82.1× FY 2025
FCF Yield -15.3%
FY 2019 5y median -1.3% FY 2025
Profitability
Gross Margin 80.6%
FY 2019 5y median 80.6% FY 2025
Operating Margin -40873.2%
FY 2019 5y median -612.4% FY 2025
Net Margin -39662.8%
FY 2019 5y median -686.4% FY 2025
ROE 471.9%
FY 2019 5y median 82.5% FY 2025
ROIC -255.4%
FY 2019 5y median 65.4% FY 2025
ROA -155.4%
FY 2019 5y median -656.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -188.2%
FY 2019 FY 2025
EPS (diluted) -194.8%
FY 2019 FY 2025
Free Cash Flow -38.4%
FY 2019 FY 2025
Financial Health
Current Ratio 0.7×
FY 2019 5y median 0.1× FY 2025
Quick Ratio 0.6×
FY 2019 5y median 0.1× FY 2025
Debt / Equity -2.9×
FY 2019 5y median -0.3× FY 2025
Net Debt / EBITDA -0.2×
FY 2019 5y median -0.2× FY 2025
Interest Coverage -135×
FY 2019 5y median -17.7× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31